A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
Boehringer Ingelheim
Boehringer Ingelheim
Mayo Clinic
Azienda USL Reggio Emilia - IRCCS
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Radboud University Medical Center
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
National Cancer Centre, Singapore
Peking Union Medical College Hospital
Moonlight Bio, Inc
Vanderbilt-Ingram Cancer Center